Skip to Content

Surfak (Docusate calcium 240 mg)

Pill imprint Surfak has been identified as Docusate calcium 240 mg.

Docusate is used in the treatment of constipation and belongs to the drug class laxatives. FDA has not classified the drug for risk during pregnancy. Docusate 240 mg is not a controlled substance under the Controlled Substance Act (CSA).

Docusate calcium
Imprint:
Surfak
Strength:
240 mg
Color:
Red
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Drug Class:
Laxatives
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Manufacturer:
Chattem, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide